Large-scale testing (Phase 3)Ended earlyNCT01927055
What this trial is testing
A Clinical Study of Patients With Symptomatic NOH to Assess Sustained Effects of Droxidopa Therapy
Who this might be right for
Symptomatic Neurogenic Orthostatic HypotensionParkinson's DiseaseMultiple Systems Atrophy+2 more
Chelsea Therapeutics 61